# VPREB1

## Overview
The VPREB1 gene encodes the V-set pre-B cell surrogate light chain 1 protein, a critical component of the pre-B cell receptor (pre-BCR) complex involved in early B-cell development. This protein, categorized as part of the immunoglobulin superfamily, forms a heterodimer with the λ5 chain, facilitating the assembly of the surrogate light chain that pairs with the immunoglobulin heavy chain. The pre-BCR complex, which includes VPREB1, plays a pivotal role in the selection and maturation of B cells by ensuring the proper rearrangement and expression of immunoglobulin genes, thereby contributing to allelic exclusion and clonal selection (Melchers2005The; Karasuyama1990The). Alterations in VPREB1 expression have been associated with various hematological malignancies, highlighting its significance in both normal immune function and disease (Khaled2021CRISPRCas9; Vasikova2010A).

## Structure
The VPREB1 protein, also known as V-set pre-B cell surrogate light chain 1, is a component of the pre-B cell receptor complex. Its primary structure includes a 19-amino acid signal peptide, which is unusual due to the presence of a proline at the -1 position, followed by a 102-amino acid sequence homologous to a conventional variable region, but lacking a J region sequence (Minegishi1999Novel). The secondary structure of VPREB1 is characterized by an immunoglobulin-like domain, which includes an 8 β-strand structure (Minegishi1999Novel). The tertiary structure of VPREB1 involves a V-type immunoglobulin fold, with a unique region of the λ5 chain completing the bottom β-sheet of this fold (Bankovich2007Structural). 

In terms of quaternary structure, VPREB1 forms a non-covalent heterodimer with the λ5 chain, which is essential for the formation of the surrogate light chain complex in the pre-B cell receptor (Karasuyama1990The). This complex is crucial for early B cell development, as it mimics a heavy/light chain-like heterocomplex (Karasuyama1990The). The VPREB1 protein may also undergo post-translational modifications, such as glycosylation, which can influence its function and stability.

## Function
The VPREB1 gene encodes a protein that is a component of the surrogate light chain, which is crucial in the early stages of B-cell development. This protein, also known as CD179a, forms a complex with the λ5 protein to create the pre-B-cell receptor (pre-BCR) by associating with the immunoglobulin heavy chain (Igµ) (Khaled2021CRISPRCas9; Melchers2005The). The pre-BCR is essential for the selection of fitting immunoglobulin heavy chains, ensuring that B cells produce only one antigen-specific immunoglobulin, a key aspect of the clonal-selection hypothesis (Melchers2005The). 

The VPREB1 protein is expressed on the surface of early pre-B cells, specifically pro-B and early pre-B cells, and plays a critical role in regulating immunoglobulin gene rearrangements during B-cell differentiation (Khaled2021CRISPRCas9). It acts as a checkpoint in early B-cell development, promoting B cell proliferation and differentiation by monitoring the production of the heavy chain and combining it with the Ig light chain (Khaled2021CRISPRCas9). The pre-BCR complex, which includes VPREB1, is involved in signaling processes that prevent further rearrangement of immunoglobulin genes, contributing to allelic exclusion and ensuring proper B-cell maturation (Melchers2005The).

## Clinical Significance
Alterations in the expression of the VPREB1 gene have been implicated in several hematological malignancies. In multiple myeloma, VPREB1 is overexpressed, and its knockout using CRISPR/Cas9 technology has been shown to reduce myeloma cell proliferation and increase cytotoxicity, suggesting its potential as a therapeutic target (Khaled2021CRISPRCas9). In myelodysplastic syndrome (MDS), VPREB1 expression is decreased, particularly in advanced stages and in cases that evolve into acute myeloid leukemia (AML), indicating a disruption in B-cell development (Vasikova2010A).

In B-cell precursor acute lymphoblastic leukemia (BCP-ALL), VPREB1 is frequently deleted in certain subtypes, such as the BCR-ABL1-like subtype, which is associated with poor clinical outcomes (Ghazavi2015Molecular). Similarly, in pediatric high-risk B-precursor acute lymphoblastic leukemia, VPREB1 deletions are linked to poor survival rates in specific gene expression clusters (Harvey2010Identification). These findings highlight the role of VPREB1 in the pathogenesis and progression of various B-cell malignancies, where its altered expression or deletion can significantly impact disease outcomes.

## Interactions
VPREB1, a component of the surrogate light chain, interacts with various proteins to form the pre-B cell receptor (preBCR) complex. It pairs with the immunoglobulin heavy (H) chain and the λ5 protein to create this complex, which is crucial for B cell development. VPREB1 can bind to certain μ heavy chains in the absence of the λ5 protein, forming a preBCR, although some μ heavy chains require λ5 for this interaction (Seidl2001The). The VPREB1 protein is essential for the proper assembly of the surrogate light chain and its association with the μ heavy chain, as it forms an Ig-variable domain-like structure that interacts with the H chain (Seidl2001The).

The interaction between VPREB1 and the H chain is significant for allelic exclusion during B cell development, as it helps prevent further rearrangements of the second H-chain allele (Seidl2001The). VPREB1 also plays a role in stabilizing the preBCR on the cell surface, as its non-Ig part is necessary for optimal surface expression (Knoll2012The). These interactions highlight the importance of VPREB1 in the formation and function of the preBCR complex, influencing B cell maturation and proliferation.


## References


[1. (Bankovich2007Structural) Alexander J. Bankovich, Stefan Raunser, Z. Sean Juo, Thomas Walz, Mark M. Davis, and K. Christopher Garcia. Structural insight into pre-b cell receptor function. Science, 316(5822):291–294, April 2007. URL: http://dx.doi.org/10.1126/science.1139412, doi:10.1126/science.1139412. This article has 88 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.1139412)

[2. (Vasikova2010A) Alzbeta Vasikova, Monika Belickova, Eva Budinska, and Jaroslav Cermak. A distinct expression of various gene subsets in cd34+ cells from patients with early and advanced myelodysplastic syndrome. Leukemia Research, 34(12):1566–1572, December 2010. URL: http://dx.doi.org/10.1016/j.leukres.2010.02.021, doi:10.1016/j.leukres.2010.02.021. This article has 24 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.leukres.2010.02.021)

[3. (Harvey2010Identification) Richard C. Harvey, Charles G. Mullighan, Xuefei Wang, Kevin K. Dobbin, George S. Davidson, Edward J. Bedrick, I-Ming Chen, Susan R. Atlas, Huining Kang, Kerem Ar, Carla S. Wilson, Walker Wharton, Maurice Murphy, Meenakshi Devidas, Andrew J. Carroll, Michael J. Borowitz, W. Paul Bowman, James R. Downing, Mary Relling, Jun Yang, Deepa Bhojwani, William L. Carroll, Bruce Camitta, Gregory H. Reaman, Malcolm Smith, Stephen P. Hunger, and Cheryl L. Willman. Identification of novel cluster groups in pediatric high-risk b-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide dna copy number alterations, clinical characteristics, and outcome. Blood, 116(23):4874–4884, December 2010. URL: http://dx.doi.org/10.1182/blood-2009-08-239681, doi:10.1182/blood-2009-08-239681. This article has 329 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2009-08-239681)

[4. (Minegishi1999Novel) Yoshiyuki Minegishi, Linda M. Hendershot, and Mary Ellen Conley. Novel mechanisms control the folding and assembly of λ5/14.1 and vpreb to produce an intact surrogate light chain. Proceedings of the National Academy of Sciences, 96(6):3041–3046, March 1999. URL: http://dx.doi.org/10.1073/pnas.96.6.3041, doi:10.1073/pnas.96.6.3041. This article has 48 citations.](https://doi.org/10.1073/pnas.96.6.3041)

[5. (Ghazavi2015Molecular) Farzaneh Ghazavi, Tim Lammens, Nadine Van Roy, Bruce Poppe, Frank Speleman, Yves Benoit, Pieter Van Vlierberghe, and Barbara De Moerloose. Molecular basis and clinical significance of genetic aberrations in b-cell precursor acute lymphoblastic leukemia. Experimental Hematology, 43(8):640–653, August 2015. URL: http://dx.doi.org/10.1016/j.exphem.2015.05.015, doi:10.1016/j.exphem.2015.05.015. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.exphem.2015.05.015)

[6. (Seidl2001The) Thomas Seidl, Antonius Rolink, and Fritz Melchers. The vpreb protein of the surrogate light-chain can pair with some μ heavy-chains in the absence of the λ 5 protein. European Journal of Immunology, 31(7):1999–2006, July 2001. URL: http://dx.doi.org/10.1002/1521-4141(200107)31:7<1999::AID-IMMU1999>3.0.CO;2-K, doi:10.1002/1521-4141(200107)31:7<1999::aid-immu1999>3.0.co;2-k. This article has 26 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/1521-4141(200107)31:7)

[7. (Khaled2021CRISPRCas9) Mai Khaled, Amr S. Moustafa, Nashwa El-Khazragy, Maha Imam Ahmed, Marwa Ali Abd Elkhalek, and Eman M. El_Salahy. Crispr/cas9 mediated knock-out of vpreb1 gene induces a cytotoxic effect in myeloma cells. PLOS ONE, 16(1):e0245349, January 2021. URL: http://dx.doi.org/10.1371/journal.pone.0245349, doi:10.1371/journal.pone.0245349. This article has 6 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0245349)

[8. (Knoll2012The) Marko Knoll, Yuki Yanagisawa, Szandor Simmons, Niklas Engels, Jürgen Wienands, Fritz Melchers, and Kazuo Ohnishi. The non-ig parts of the vpreb and λ5 proteins of the surrogate light chain play opposite roles in the surface representation of the precursor b cell receptor. The Journal of Immunology, 188(12):6010–6017, June 2012. URL: http://dx.doi.org/10.4049/jimmunol.1200071, doi:10.4049/jimmunol.1200071. This article has 15 citations.](https://doi.org/10.4049/jimmunol.1200071)

[9. (Melchers2005The) Fritz Melchers. The pre-b-cell receptor: selector of fitting immunoglobulin heavy chains for the b-cell repertoire. Nature Reviews Immunology, 5(7):578–584, July 2005. URL: http://dx.doi.org/10.1038/nri1649, doi:10.1038/nri1649. This article has 147 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nri1649)

[10. (Karasuyama1990The) H Karasuyama, A Kudo, and F Melchers. The proteins encoded by the vpreb and lambda 5 pre-b cell-specific genes can associate with each other and with mu heavy chain. The Journal of experimental medicine, 172(3):969–972, September 1990. URL: http://dx.doi.org/10.1084/jem.172.3.969, doi:10.1084/jem.172.3.969. This article has 271 citations.](https://doi.org/10.1084/jem.172.3.969)